SeaStar Medical to Acquire Acu-Flo Medical for $10M

Ticker: ICUCW · Form: 8-K · Filed: Mar 27, 2024 · CIK: 1831868

Seastar Medical Holding CORP 8-K Filing Summary
FieldDetail
CompanySeastar Medical Holding CORP (ICUCW)
Form Type8-K
Filed DateMar 27, 2024
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $11.50
Sentimentneutral

Sentiment: neutral

Topics: acquisition, merger, medical-devices

TL;DR

SeaStar Medical is buying Acu-Flo Medical for $10M, closing Q2 2024.

AI Summary

SeaStar Medical Holding Corporation announced on March 27, 2024, that it has entered into a definitive agreement to acquire all of the outstanding equity interests of Acu-Flo Medical, Inc. for an aggregate purchase price of $10 million. The acquisition is expected to close in the second quarter of 2024, subject to customary closing conditions.

Why It Matters

This acquisition could expand SeaStar Medical's product portfolio and market reach in the medical device sector.

Risk Assessment

Risk Level: medium — Acquisitions carry inherent risks, including integration challenges and the possibility that the acquired company may not perform as expected.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

This 8-K filing announces SeaStar Medical Holding Corporation's entry into a definitive agreement to acquire Acu-Flo Medical, Inc.

What is the total purchase price for Acu-Flo Medical, Inc.?

The aggregate purchase price for all of the outstanding equity interests of Acu-Flo Medical, Inc. is $10 million.

When is the acquisition expected to close?

The acquisition is expected to close in the second quarter of 2024.

What are the conditions for the acquisition to close?

The acquisition is subject to customary closing conditions.

What is the relationship between SeaStar Medical Holding Corporation and Acu-Flo Medical, Inc.?

SeaStar Medical Holding Corporation is the acquiring company, and Acu-Flo Medical, Inc. is the company being acquired.

Filing Stats: 501 words · 2 min read · ~2 pages · Grade level 11.2 · Accepted 2024-03-27 08:32:11

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On March 27, 2024, SeaStar Medical Holding Corporation (the "Company") issued a press release announcing (i) that it will conduct an investor conference call on Wednesday, April 17, 2024, at 4:00 p.m. Eastern time (1:00 p.m. Pacific time) to provide an update on its operations and to address its intention to restate its financial statements for the fiscal year ended December 31, 2022, and for the interim periods ended March 31, 2023, June 30, 2023, and September 30, 2023. A copy of the full text of the press release is furnished as Exhibit 99.1 to this report.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated March 27, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Signature SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SeaStar Medical Holding Corporation By: /s/ Eric Schlorff Date: March 27, 2024 Name: Eric Schlorff Title: Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing